Director, Corporate Securities & Governance Counsel
Cytokinetics
Summary
Cytokinetics is seeking an experienced Director, Counsel, Corporate Securities & Governance Counsel to support public company SEC compliance, corporate governance, Board of Directors administration and strategic financial transactions. This role will serve as a key legal partner to Finance, Investor Relations, and Executive Leadership, ensuring compliance with U.S. securities laws and supporting capital markets activities. This position will report to the SVP, Deputy General Counsel and Corporate Secretary.
Job description
Key Responsibilities
- Prepare SEC filings, including Exchange Act reporting (Forms 10-K, 10-Q, 8-K), proxy statements, and Section 16 filings
- Advise on disclosure controls and procedures, earnings releases, investor presentations, and investor communications
- Support capital markets transactions, including equity offerings, debt financings, and other programs
- Advise on corporate governance matters, including Board and committee support, charter documents, and corporate policies
- Partner closely with Finance, Accounting, Investor Relations, HR, and external counsel to ensure accurate and timely disclosures
- Monitor and advise on developments in securities law, SEC rules, and governance best practices
- Support insider trading compliance, equity compensation matters, and Rule 10b5-1 plans
- Assist with ESG disclosures and related governance initiatives, as applicable
Qualifications
- J.D. from an accredited law school; active bar membership in at least one U.S. jurisdiction
- 8+ years of relevant Corporate Securities experience, including public company securities work
- Experience at a leading law firm and/or in-house at a publicly traded company; life sciences or biotech experience strongly preferred
- Deep knowledge of U.S. securities laws, SEC reporting requirements, and corporate governance
- Experience supporting capital markets transactions and interacting with senior executives and boards
- Strong drafting, analytical, and communication skills
- Ability to manage multiple priorities with a high degree of accuracy and judgment
Requirements
- J.D. from an accredited law school
- Active bar membership in at least one U.S. jurisdiction
- 8+ years of relevant Corporate Securities experience, including public company securities work
- Experience at a leading law firm and/or in-house at a publicly traded company
- Deep knowledge of U.S. securities laws, SEC reporting requirements, and corporate governance
- Experience supporting capital markets transactions and interacting with senior executives and boards
- Strong drafting, analytical, and communication skills
- Ability to manage multiple priorities with a high degree of accuracy and judgment
Benefits
- Stock options
- Restricted stock units
- Medical, Dental & Vision
- Life insurance
- Disability insurance
- 401(k) Matching
- Learning stipends
- Wellness stipends
- Paid time off
Company overview
Cytokinetics, Incorporated is a late-stage biopharmaceutical company headquartered in South San Francisco, California, specializing in muscle biology research and drug development. Founded in 1997 by leading scientists from Stanford, UCSD, and UCSF, the company focuses on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors for debilitating diseases characterized by impaired or declining muscle function. With over 25 years of scientific expertise, Cytokinetics has built a robust pipeline targeting cardiovascular and neuromuscular conditions including heart failure, hypertrophic cardiomyopathy, and amyotrophic lateral sclerosis (ALS). The company's innovative approach centers on directly targeting the sarcomere, the fundamental unit of muscle contraction, to develop potential treatments that may preserve and extend independence for patients. Cytokinetics operates as a publicly traded company (NASDAQ: CYTK) and has established itself as a leader in muscle biology with more than 115 publications, over 100 clinical trials, and hundreds of issued patents.